Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity.
Journal article
Amini A. et al, (2024), Current opinion in virology, 67
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity.
Journal article
Liu C. et al, (2024), Cell reports. Medicine
Antibody, not Cellular, Immune Responses to SARS-CoV-2 Vaccination Outperform Infection in Inflammatory Bowel Disease Patients.
Journal article
González Cueto E. et al, (2024), Inflammatory bowel diseases, 30, 859 - 862
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms
Journal article
Citarella BW. et al, (2024), Heliyon, e29591 - e29591
Fine needle aspiration of human lymph nodes reveals cell populations and soluble interactors pivotal to immunological priming
Journal article
Provine NM. et al, (2024), European Journal of Immunology, 54
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
Journal article
Goodyear CS. et al, (2024), The Lancet. Rheumatology
MAIT cell-MR1 reactivity is highly conserved across multiple divergent species.
Journal article
Edmans MD. et al, (2024), The Journal of biological chemistry
Neurodegenerative fluid biomarkers are enriched in human cervical lymph nodes
Preprint
Al-Diwani A. et al, (2024)
Impact of the COVID-19 pandemic on routine surveillance for adults with chronic hepatitis B virus (HBV) infection in the UK
Preprint
Campbell C. et al, (2024)
Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease
Journal article
Drury RE. et al, (2024), Nature Communications, 15
Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recovery
Journal article
Ali M. et al, (2024), Clinical and Experimental Immunology
Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium
Journal article
Nhu LNT. et al, (2024), Wellcome Open Research, 9, 181 - 181
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.
Journal article
Liu C. et al, (2024), Nature communications, 15
IL-5 antagonism reverses priming and activation of eosinophils in severe eosinophilic asthma.
Journal article
Luo J. et al, (2024), Mucosal immunology
Sex differences in post-acute neurological sequelae of SARS-CoV-2 and symptom resolution in adults after coronavirus disease 2019 hospitalization: an international multi-centre prospective observational study
Journal article
Cho S-M. et al, (2024), Brain Communications, 6
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.
Journal article
Zhou D. et al, (2024), Nature communications, 15
A single cell atlas of frozen shoulder capsule identifies features associated with inflammatory fibrosis resolution.
Journal article
Ng MTH. et al, (2024), Nature communications, 15
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
Journal article
Elneima O. et al, (2024), International Journal of Epidemiology, 53
Emerging Enterovirus A71 Subgenogroup B5 Causing Severe Hand, Foot, and Mouth Disease, Vietnam, 2023
Journal article
Chau NVV. et al, (2024), Emerging Infectious Diseases, 30